Differential effects of two citrus flavanones on bone quality in senescent male rats in relation to their bioavailability and metabolism

Bone

Volumn 49, Issue 5, 2011, Pages 1108-1116

  Habauzit, Véronique ^a   Sacco, Sandra Maria ^b   Gil Izquierdo, Angel ^c   Trzeciakiewicz, Anna ^a   Morand, Christine ^a   Barron, Denis ^b   Pinaud, Stéphane ^b   Offord, Elisabeth ^b   Horcajada, Marie Noëlle ^a,b  

^a INRA and University of Auvergne   (France)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

^c RESEARCH GROUP ON QUALITY   (Spain)

Author keywords

Anti inflammation; Bioavailability; Bone integrity; Hesperidin; Naringin; Resorption

Indexed keywords

AURANTIIN; BONE MORPHOGENETIC PROTEIN 2; CHOLESTEROL; HESPERIDIN; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE; OSTEOCALCIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MASS; BONE METABOLISM; CHOLESTEROL BLOOD LEVEL; CITRUS FRUIT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; FEMUR; INTESTINE ABSORPTION; MALE; METABOLIC REGULATION; METAPHYSIS; MONOTHERAPY; NONHUMAN; OSSIFICATION; OSTEOLYSIS; PROTEIN EXPRESSION; RAT; SENESCENCE; TIBIA; TRABECULAR BONE; TRIACYLGLYCEROL BLOOD LEVEL;

AGING; ANIMALS; BASE SEQUENCE; BODY WEIGHT; BONE AND BONES; BONE DENSITY; CITRUS; DNA PRIMERS; FLAVANONES; MALE; ORGAN SIZE; RATS; RATS, WISTAR; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 80054844528     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.07.030     Document Type: Article

References (53)

1. Manach C., Scalbert A., Morand C., Remesy C., Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004, 79:727-747.
2. Kyle J.A.M., Duthie G.G. Flavonoids in foods. Flavonoids: chemistry, biochemistry and applications 2006, 319-370. CRC Press, Boca Raton. O.M. Andersen, K.R. Markham (Eds.).
3. Setchell K.D.R., Lydeking-Olsen E. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr 2003, 78:593S-609S.
4. Mink P.J., Scrafford C.G., Barraj L.M., Harnack L., Hong C.P., Nettleton J.A., et al. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 2007, 85:895-909.
5. Horcajada M.N., Habauzit V., Trzeciakiewicz A., Morand C., Gil-Izquierdo A., Mardon J., et al. Hesperidin inhibits ovariectomized-induced osteopenia and shows differential effects on bone mass and strength in young and adult intact rats. J Appl Physiol 2008, 104:648-654.
6. Chiba H., Uehara M., Wu J., Wang X.X., Masuyama R., Suzuki K., et al. Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. J Nutr 2003, 133:1892-1897.
7. Horcajada M.N., Coxam V. Hesperidin, a citrus flavanone, improves bone acquisition and prevents skeletal impairment in rats. Nutritional aspects of osteoporosis 2004, 103-120. P. Burckardt, B. Dawson-Hughes, R.P. Heaney (Eds.).
8. Habauzit V., Nielsen I.L., Gil-Izquierdo A., Trzeciakiewicz A., Morand C., Chee W., et al. Increased bioavailability of hesperetin-7-glucoside compared with hesperidin results in more efficient prevention of bone loss in adult ovariectomised rats. Br J Nutr 2009, 1-9.
9. Muhlbauer R.C., Lozano A., Reinli A., Wetli H. Various selected vegetables, fruits, mushrooms and red wine residue inhibit bone resorption in rats. J Nutr 2003, 133:3592-3597.
10. Deyhim F., Garica K., Lopez E., Gonzalez J., Ino S., Garcia M., et al. Citrus juice modulates bone strength in male senescent rat model of osteoporosis. Nutrition 2006, 22:559-563.
11. Bok S.H., Lee S.H., Park Y.B., Bae K.H., Son K.H., Jeong T.S., et al. Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl-CoA reductase and acyl CoA: cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids. J Nutr 1999, 129:1182-1185.
12. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999, 286:1946-1949.
13. Sugiyama M., Kodama T., Konishi K., Abe K., Asami S., Oikawa S. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells. Biochem Biophys Res Commun 2000, 271:688-692.
14. Trzeciakiewicz A., Habauzit V., Mercier S., Lebecque P., Davicco M.J., Coxam V., et al. Hesperetin stimulates differentiation of primary rat osteoblasts involving the BMP signalling pathway. J Nutr Biochem 2010, 21:424-431.
15. Trzeciakiewicz A., Habauzit V., Mercier S., Barron D., Urpi-Sarda M., Manach C., et al. Molecular mechanism of hesperetin-7-O-glucuronide, the main circulating metabolite of hesperidin, involved in osteoblast differentiation. J Agric Food Chem 2010, 58:668-675.
16. Kim J.Y., Jung K.J., Choi J.S., Chung H.Y. Modulation of the age-related nuclear factor-kappaB (NF-kappaB) pathway by hesperetin. Aging Cell 2006, 5:401-411.
17. Asagiri M., Takayanagi H. The molecular understanding of osteoclast differentiation. Bone 2007, 40:251-264.
18. Reid I.R. Relationships between fat and bone. Osteoporos Int 2008, 19:595-606.
19. Wolf G. Energy regulation by the skeleton. Nutr Rev 2008, 66:229-233.
20. Chung H.Y., Cesari M., Anton S., Marzetti E., Giovannini S., Seo A.Y., et al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev 2009, 8:18-30.
21. Wang L., Banu J., McMahan C.A., Kalu D.N. Male rodent model of age-related bone loss in men. Bone 2001, 29:141-148.
22. Garg A., Garg S., Zaneveld L.J., Singla A.K. Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytother Res 2001, 15:655-669.
23. Ding C., Parameswaran V., Udayan R., Burgess J., Jones G. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab 2008, 93:1952-1958.
24. Dennison E.M., Syddall H.E., Aihie Sayer A., Martin H.J., Cooper C. Lipid profile, obesity and bone mineral density: the Hertfordshire Cohort Study. QJM 2007, 100:297-303.
25. Adami S., Braga V., Zamboni M., Gatti D., Rossini M., Bakri J., et al. Relationship between lipids and bone mass in 2 cohorts of healthy women and men. Calcif Tissue Int 2004, 74:136-142.
26. Clarke B.L., Khosla S. Physiology of bone loss. Radiol Clin North Am 2010, 48:483-495.
27. Allen M.J. Biochemical markers of bone metabolism in animals: uses and limitations. Vet Clin Pathol 2003, 32:101-113.
28. Ohlsson C., Mellstrom D., Carlzon D., Orwoll E., Ljunggren O., Karlsson M.K., et al. Older men with low serum IGF-1 have an increased risk of incident fractures: the MrOS Sweden study. J Bone Miner Res 2011, 26:865-872.
29. Omi N., Ezawa I. The effect of ovariectomy on bone metabolism in rats. Bone 1995, 17:163S-168S.
30. Turner C.H., Burr D.B. Basic biomechanical measurements of bone: a tutorial. Bone 1993, 14:595-608.
31. Rubinacci A., Melzi R., Zampino M., Soldarini A., Villa I. Total and free deoxypyridinoline after acute osteoclast activity inhibition. Clin Chem 1999, 45:1510-1516.
32. Robins S.P. Biochemical markers for assessing skeletal growth. Eur J Clin Nutr 1994, 48(Suppl 1):S199-S209.
33. Cook J.G. Factors influencing the assay of creatinine. Ann Clin Biochem 1975, 12:219-232.
34. Moshage H., Kok B., Huizenga J.R., Jansen P.L. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem 1995, 41:892-896.
35. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001, 25:402-408.
36. Silberberg M., Gil-Izquierdo A., Combaret L., Remesy C., Scalbert A., Morand C. Flavanone metabolism in healthy and tumor-bearing rats. Biomed Pharmacother 2006, 60:529-535.
37. Turner C.H., Roeder R.K., Wieczorek A., Foroud T., Liu G., Peacock M. Variability in skeletal mass, structure, and biomechanical properties among inbred strains of rats. J Bone Miner Res 2001, 16:1532-1539.
38. Morrow R., Deyhim F., Patil B.S., Stoecker B.J. Feeding orange pulp improved bone quality in a rat model of male osteoporosis. J Med Food 2009, 12:298-303.
39. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992, 6:3051-3064.
40. Wimalawansa S.J. Nitric oxide and bone. Ann N Y Acad Sci 2010, 1192:391-403.
41. Nanes M.S. Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene 2003, 321:1-15.
42. Ershler W.B., Keller E.T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 2000, 51:245-270.
43. Santangelo C., Vari R., Scazzocchio B., Di Benedetto R., Filesi C., Masella R. Polyphenols, intracellular signalling and inflammation. Ann Ist Super Sanita 2007, 43:394-405.
44. McCarthy T.L., Centrella M. Local IGF-1 expression and bone formation. Growth Horm IGF Res 2001, 11:213-219.
45. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139:4252-4263.
46. Larocca L.M., Piantelli M., Leone G., Sica S., Teofili L., Panici P.B., et al. Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoids. Br J Haematol 1990, 75:489-495.
47. Breinholt V., Larsen J.C. Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay. Chem Res Toxicol 1998, 11:622-629.
48. Crespy V., Morand C., Besson C., Cotelle N., Vezin H., Demigne C., et al. The splanchnic metabolism of flavonoids highly differed according to the nature of the compound. Am J Physiol Gastrointest Liver Physiol 2003, 284:G980-G988.
49. Silberberg M., Besson C., Manach C., Remesy C., Morand C. Influence of dietary antioxidants on polyphenol intestinal absorption and metabolism in rats. J Agric Food Chem 2006, 54:3541-3546.
50. Silberberg M., Morand C., Mathevon T., Besson C., Manach C., Scalbert A., et al. The bioavailability of polyphenols is highly governed by the capacity of the intestine and of the liver to secrete conjugated metabolites. Eur J Nutr 2006, 45:88-96.
51. Matsumoto H., Ikoma Y., Sugiura M., Yano M., Hasegawa Y. Identification and quantification of the conjugated metabolites derived from orally administered hesperidin in rat plasma. J Agric Food Chem 2004, 52:6653-6659.
52. Manach C., Williamson G., Morand C., Scalbert A., Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005, 81:230S-242S.
53. Silberberg M., Morand C., Manach C., Scalbert A., Remesy C. Co-administration of quercetin and catechin in rats alters their absorption but not their metabolism. Life Sci 2005, 77:3156-3167.